CNBC Dubai: Prof. Polosa speaker on Harm Reduction
Among the distinguished speakers, also the expected speech by prof. Riccardo Polosa, founder of CoEHAR.
Riccardo Polosa at the National Congress of the Italian Society of Internal Medicine
Harm Reduction strategies were the subject of a speech by prof. Polosa during the National Congress of the Italian Society of Internal Medicine. Focus of this year edition, the management of…
Washington, GTNF 2022: Polosa attending a panel on vaping prohibition
During the 2022 edition of GTNF, the Global Tobacco and Nicotine Forum, Prof. Riccardo Polosa, founder of the CoEHAR, was part of an intense and engaging panel on vaping and tobacco policies at the panel “Banned! Is Prohibition Back?”.
Genesis and Ceasefire: new CoEHAR research project at AIP2022
Pasquale Caponnetto, CoEHAR member, unveiled two brand new research project during the XXX Congress of the Italian Association of Psychology, Genesis and Ceasefire. Two projects concerning mental health, smoking addiction and combustion-free products
Mirroring human mental processes through artificial intelligence can open new frontiers in clinical medicine
Just published in the journal Internal and Emergency Medicine a commentary that illustrates the potential of machine learning in analyzing and processing large amounts of clinical and laboratory information, using…
Study showed that vaping is linked to respiratory symptoms but according to CoEHAR researchers: “No causality proved”
The prestigious American Journal of Respiratory and Critical Care Medicine published a comment by researchers from CoEHAR and the University of Messina regarding a US studies that concluded that “former and current e-cigarette use was associated with higher odds of developing wheezing-related respiratory symptoms”. According to the Italian authors “the significance of the findings needs careful review”.
Evidence for Clinicians: E-Cigarettes a Better Chance at Health
The In Silico Science research team conducted a series of robust and exhaustive systematic reviews to bring forward the best available evidence on the health effects of e-cigarettes on human health developing data for clinicians
Covid-19: ecig only add 1% of risk compared to breathing
Incredibly, people close to an infected vaper using an e-cigarette in home or restaurant scenarios face a one percent increase of risk of contagion compared to the control case of a normal breathing (without vaping) inside closed spaces. This relative added risk becomes 5-17 percent for high intensity vaping and up to 260 percent for speaking for various periods and coughing.
US: end of teen nicotine vaping epidemic and eradication of tobacco smoking
The use of e-cigarette among teenagers in the United States is considered a significant public health problem. A close look at federal data now show that the number of young e-cigarette users has markedly declined to below epidemic levels since its peak in 2019.
The first review to assess the metabolic impact of stopping smoking in patients with diabetes mellitus revealed serious gaps in the literature
Quitting smoking can reduce cardiovascular and kidney failure risks. However, it can lead to side effects such as weight gain. A scoping review conducted by a pool of European researchers revealed a lack of data on the metabolic effects of smoking and smoking cessation in diabetes. Healthcare professionals should not assume that cessation of smoking will improve metabolic parameters in patients with diabetes.
- Go to the previous page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- …
- 12
- Go to the next page
